Institutional investors purchased a net $172.3 thousand shares of DSCO during the quarter ended December 2012 and now own 48.47% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Mutual fund holders | 24.69% |
| Other institutional | 23.79% |
| Individual stakeholders | 1.25% |